| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238723 Indole derivatives |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238710 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238705 Aporphine esters and their use in therapy |
| 07/03/2007 | US7238697 Insecticides for crops |
| 07/03/2007 | US7238696 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | CA2211312C Alkylene oxide catalyst and process |
| 07/03/2007 | CA2188306C Process for the diastereoselective synthesis of nucleoside analogues |
| 07/03/2007 | CA2168021C Vasoconstrictive dihydrobenzopyran derivatives |
| 06/28/2007 | WO2007073462A1 Photochromic materials having electron-withdrawing substituents |
| 06/28/2007 | WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | WO2007073300A1 Gaba-b receptor modulators |
| 06/28/2007 | WO2007072146A1 Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 06/28/2007 | WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 06/28/2007 | WO2007071434A1 Antiviral 2-carboxy-thiophene compounds |
| 06/28/2007 | WO2007071348A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 06/28/2007 | WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
| 06/28/2007 | WO2007026920A3 Amide derivatives as rock inhibitors |
| 06/28/2007 | WO2007022938A3 Compounds |
| 06/28/2007 | US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 06/28/2007 | US20070149603 Ppar active compounds |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149558 Benzo-fused 5-membered heterocyclic compounds, their production and use |
| 06/28/2007 | US20070149550 Substituted arylpyrazoles |
| 06/28/2007 | US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use |
| 06/28/2007 | US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 06/28/2007 | US20070149541 Imidazole compounds |
| 06/28/2007 | US20070149537 NK1 and NK2-antagonists and compositions and methods of using the same |
| 06/28/2007 | US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative |
| 06/28/2007 | US20070149519 Benzimidazol substituted thiopene derivatives with activity on ikk3 |
| 06/28/2007 | US20070149503 Anti-migraine spirocycles |
| 06/28/2007 | US20070149502 Spirocyclic anti-migraine compounds |
| 06/28/2007 | US20070149406 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE102005062742A1 Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel Sulfoximine substituted pyrimidines, process for their preparation and their use as medicaments |
| 06/28/2007 | DE102005059279A1 Fungizid oder antimykotisch wirkende Verbindungen Fungicide or antifungal acting compounds |
| 06/28/2007 | CA2634804A1 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/28/2007 | CA2633101A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 06/28/2007 | CA2632929A1 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 06/28/2007 | CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs |
| 06/28/2007 | CA2632582A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | CA2632021A1 Gaba-b receptor modulators |
| 06/28/2007 | CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/27/2007 | EP1799674A1 New piperidine antibiotics |
| 06/27/2007 | EP1799652A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 06/27/2007 | EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799206A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/27/2007 | EP1740574B1 4-amino-5-cyanopyrimidine derivatives |
| 06/27/2007 | EP1636212B1 Cycloalkylsulfanyl substituted benzo¬b|thiophenes as therapeutic agents |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1028959B1 Herbicidal furanyl- and thienyloxyazines |
| 06/27/2007 | CN1989132A Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 06/27/2007 | CN1989131A Substituted thiophene derivatives as anti-cancer agents |
| 06/27/2007 | CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 06/27/2007 | CN1989113A 喹唑啉衍生物 Quinazoline derivatives |
| 06/27/2007 | CN1988908A Amido compounds and their use as pharmaceuticals |
| 06/27/2007 | CN1988907A Dual small molecule inhibitors of cancer and angiogenesis |
| 06/26/2007 | USRE39708 Estrogen receptor modulators |
| 06/26/2007 | US7235674 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 06/26/2007 | US7235584 Dibenzo[b,d]pyran derivatives as neuroprotectant, antiinflammatory, and antiischemic agents; brain, cardiovascular, neurodegenerative, autoimmune and nervous system disorders; Grave*s, Hashimoto*s, Alzheimer*s, Parkinson*s, and Huntington*s disease; amyotrophic lateral sclerosis; drug abuse, alcoholism |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235571 Insecticides; for human or veterinary medicine |
| 06/26/2007 | US7235569 5-HT1A receptor antagonists and serotonin uptake inhibitors; increasing levels of serotonin in synapse and reducing latency period; psychological disorders |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235560 Pyrimidine derivative as selective COX-2 inhibitors |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2155014C Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | WO2007070201A1 Aspartic protease inhibitors |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069569A1 Organic electroluminescence element material and organic electroluminescence element using same |
| 06/21/2007 | WO2007068621A1 Novel fused pyrrole derivatives |
| 06/21/2007 | WO2007068375A1 Carboxamides for controlling undesired micro-organisms in plant protection |
| 06/21/2007 | WO2007068373A1 Carboxamides |
| 06/21/2007 | WO2007048064A3 Amino-pyrimidines as casein kinase ii (ck2) modulators |
| 06/21/2007 | WO2007045462A3 Novel vanilloid receptor ligands and their use for producing medicaments |
| 06/21/2007 | US20070142452 Fused pyrrole derivatives |
| 06/21/2007 | US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor |
| 06/21/2007 | US20070142435 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase |
| 06/21/2007 | US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |